The success of AI in healthcare is influenced more by human factors and organizational readiness than by the technology ...

This month’s focus on pharmaphorum is clinical trials, so who better to share their view on global clinical trials than Zheng Su, Editor-in-Chief of the Contemporary Clinical Trials journal.

We recently published a list of 10 Best Cancer Stocks to Invest in for Long-Term Gains. In this article, we are going to take ...

Here is our list of the 10 best cancer stocks to invest in for long term gains. Summit Therapeutics Inc. (NASDAQ:SMMT) is a ...

Cambridge, Massachusetts-based Vor Bio has confirmed that it will halt clinical and manufacturing operations, including its ...

The year 2025 marks a historic milestone for Critical Path Institute® (C-Path), as the organization celebrates 20 years of transforming the landscape of drug development through collaboration, ...

Discover how AI is transforming healthcare with insights from Microsoft leaders on AI advancements, success stories, and ...

FDA's plan to deploy an AI tool to assist with scientific review process raises questions about transparency and risks.

Commissioner Martin Makary also said the agency would roll out a generative AI system across its centers that will help FDA ...

Donald Trump has promised to create a pro-AI environment, but even tech companies are frustrated by federal cuts that hamper regulatory processes. Paul Webster reports.

The U.S. Food and Drug Administration (FDA) on Thursday announced an expedited plan to implement artificial intelligence (AI) ...

The U.S. Food and Drug Administration plans to integrate generative artificial intelligence across all its centers by June 30, 2025, following a successful pilot program. Here are five things to know: ...